Trial Profile
Differences in attitudes toward pre-exposure prophylaxis (PrEP) among three key populations heterosexuals, men who have sex with men (MSM), and people who inject drugs (PWID)
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2017
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 30 Aug 2017 New trial record
- 26 Jul 2017 Results presented at the 9th International AIDS Society Conference on HIV Science